A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates

We recently reported the clinical results of a Phase I trial combining ipilimumab with a vaccine containing transgenes for prostate-specific antigen (PSA) and for a triad of costimulatory molecules (PROSTVAC) in patients with metastatic castration-resistant prostate cancer. Thirty patients were trea...

詳細記述

保存先:
書誌詳細
出版年:Cancer Immunol Immunother
主要な著者: Jochems, Caroline, Tucker, Jo A., Tsang, Kwong-Yok, Madan, Ravi A., Dahut, William L., Liewehr, David J., Steinberg, Seth M., Gulley, James L., Schlom, Jeffrey
フォーマット: Artigo
言語:Inglês
出版事項: Springer Berlin Heidelberg 2014
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6314199/
https://ncbi.nlm.nih.gov/pubmed/24514956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-014-1524-0
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料